Regeneron Pharmaceuticals(REGN) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist

638.610
-22.390-3.39%

Trading Mar 25 14:33 ET

69.82BMarket Cap16.66P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
Barron'sMar 25 00:01 ET
Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls
BenzingaMar 24 11:26 ET
Opthea Phase 3 Trial Fails To Meet Primary Endpoint, Faces Financial Uncertainty
BenzingaMar 24 09:18 ET
Express News | FOMC Projects Lower GDP and Uncertainty, No Rate Change
Moomoo NewsMar 19 13:50 ET
Fed Dot Plot in Full View as Market Holds on a Higher Note: Live Stock News
Kevin TraversMar 19 10:40 ET
Regeneron Pharmaceuticals' (NASDAQ:REGN) Earnings Growth Rate Lags the 8.3% CAGR Delivered to Shareholders
Simply Wall StMar 18 15:31 ET

Comments

韭菜变主力

Mar 19 11:50

$Regeneron Pharmaceuticals (REGN.US)$ Sold my trading position at 734. Put a limit buy order at around 600 to wait for the gap fill. The 200 week moving average is a key resistance. The company has to prove the Eylea franchise revenue will not be significantly eroded by biosimilars.